Lite Strategy (LITS) EBT Margin (QoQ) (2016 - 2023)
Lite Strategy (LITS) EBT Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - |
| 10 | Lite Strategy | 36.96 Mn | 29.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 80,754.00 |
| Jun 30, 2023 | -17,710.00 |
| Mar 31, 2023 | -56,652.00 |
| Dec 31, 2022 | 42,745.00 |
| Sep 30, 2022 | -26,683.00 |
| Jun 30, 2022 | 8,227.00 |
| Mar 31, 2022 | -4,775.00 |
| Dec 31, 2021 | 13,442.00 |
| Sep 30, 2021 | 61,557.00 |
| Jun 30, 2021 | -60,590.00 |
| Mar 31, 2021 | -10,731.00 |
| Dec 31, 2020 | 7,644.00 |
| Sep 30, 2020 | -33,740.00 |
| Jun 30, 2020 | 104,451.00 |
| Mar 31, 2020 | 43,218.00 |
| Dec 31, 2019 | -32,837.00 |
| Sep 30, 2019 | 332,726.00 |
| Jun 30, 2019 | -308,532.00 |
| Mar 31, 2019 | -63,184.00 |
| Dec 31, 2018 | 343,802.00 |